Pet medicine report lookup / Deracoxib / Dogs

What has been reported to the FDA for Deracoxib in dogs?

Short answer: The FDA has received 11,012 adverse event reports for dogs that name Deracoxib. The FDA lists 3 approved animal drug applications containing Deracoxib for dogs, the earliest approved in 2002. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Deracoxibin dogs
11,012reports to the FDA

The FDA has received 11,012 adverse event reports for dogs that name Deracoxib.

  1. 11,012 reports name Deracoxib in dogs, which is 1.1% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
  2. 15% are marked serious and 21% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
  3. 4.0% are complaints that the product did not work (38% across all dog reports).
  4. The clinical signs reported most are vomiting, anorexia and depression.
  5. The FDA lists 3 approved animal drug applications containing Deracoxib for dogs, the earliest approved in 2002.
  6. None of this is a rate. The FDA data does not record how many dogs were given Deracoxib, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll dog reports
Marked seriousthe FDA record flags the report as serious1,70415%29%
Death or euthanasiathe outcome recorded in the report, with no finding of cause2,30221%5.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event4414.0%38%
Seizurea seizure or convulsion is among the clinical signs4524.1%4.4%
Not used per labelthe report says the product was not used the way its label directs5,54650%21%

Where on the body do the reported signs sit?

39%37%6.6%4.3%

Not on the body: Whole body 8.1% How it was given 5.2%

  1. Blood and organ tests39%elevated blood urea nitrogen (bun), elevated serum alkaline phosphatase (sap), elevated creatinine, elevated alanine aminotransferase (alt) and 7 more
  2. Stomach and gut37%vomiting, anorexia, diarrhoea, weight loss and 4 more
  3. Whole body8.1%death by euthanasia, death
  4. Behaviour6.6%depression
  5. How it was given5.2%accidental exposure
  6. Thirst and urination4.3%polydipsia, dehydration

Each figure is a share of sign mentions among the 25 signs reported most for Deracoxib in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Vomiting3,380 31%
  2. Anorexia2,421 22%
  3. Depression1,849 17%
  4. Elevated blood urea nitrogen (BUN)1,672 15%
  5. Elevated serum alkaline phosphatase (SAP)1,610 15%
  6. Diarrhoea1,478 13%
  7. Accidental exposure1,440 13%
  8. Elevated creatinine1,416 13%

Reports received per year

37802012: 304 reports2013: 219 reports2014: 276 reports2015: 286 reports2016: 248 reports2017: 378 reports2018: 248 reports2019: 184 reports2020: 165 reports2021: 122 reports2022: 71 reports2023: 94 reports2024: 73 reports2025: 92 reports2026: 43 reports20122014201620182020202220242026
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 378 reports (2017). The highest year on record was earlier, 2004, with 1,873 reports. The earliest FDA approval for dogs was in 2002.

Is it approved for dogs?

DogsFDA-approved product listed
Catsno approved product found
Other animalsnone found
FDA-approved for dogs

The FDA lists 3 approved animal drug applications containing Deracoxib for dogs, the earliest approved in 2002.

ProductFormApproved forFirst approvedFDA application
Deramaxx Chewable TabletsElanco US Inc.Chewable Tablets RXDog2002141-203
DoxidylCeva Sante AnimaleChewable Tablets RXDog2019200-637
Deracoxib Chewable TabletsFelix Pharmaceuticals Pvt. Ltd.Chewable Tablets RXDog2021200-704

From the FDA record for Deramaxx Chewable Tablets: Dogs needing a dose of less than 12.5 mg can only be accurately dosed through use of the 12 mg tablet, which can be broken in half to provide 6 mg. Do not attempt to accurately dose smaller dogs through the use of breaking larger tablets. For oral use in dogs only. Do not use in cats. Federal Law (U.S.) restricts this drug to use by or on the order of a licensed veterinarian.

What can you do next?

Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save